Association of Viruses in the Development of Cardiovascular Diseases

Author:

Rauff Bisma1ORCID,Malik Arif2ORCID,Bhatti Yasir A.3ORCID,Chudhary Shafiq A.4ORCID,Fatima Kaneez5ORCID,Rafiq Shafquat6ORCID,Tahir Aisha7ORCID,Sharif Sumaira2ORCID,Qadri Ishtiaq8ORCID

Affiliation:

1. Storr Liver Centre, Westmead Institute for Medical Research, Westmead Hospital and University of Sydney, NSW Sydney, Australia

2. Institute of Molecular Biology and Biotechnology (IMBB), University of Lahore, Lahore, Pakistan

3. Avecina Medical College, Lahore, Pakistan

4. Institute of Biomedical and Allied Health Sciences (IBAHS), University of Health Sciences, Lahore, Pakistan

5. Department of Biology, University of Jeddah, Jeddah, Saudi Arabia

6. Department of Gastrointestinal Medicine, Croydon University Hospital NHS Trust, 503 London Road, Croydon CR7 7YE, United Kingdom

7. Department of Biochemistry, University of Health Sciences, Lahore, Pakistan

8. King Fahd Medical Research Center, King Abdul Aziz University, Jeddah, Saudi Arabia

Abstract

Cardiovascular diseases (CVD), primarily inflammatory cardiomyopathy, are characterized by the infiltration of inflammatory cells into the myocardium. It has a relatively high risk of deteriorating heart function and has heterogeneous etiologies. Inflammatory cardiomyopathy is mainly mediated by viral infections but can also be mediated by protozoa, fungal or bacterial infections. Besides that, there are a wide variety of drugs, toxic substances, and systemic immune-mediated diseases that result in the development of cardiovascular diseases (CVDs). Despite broad research, inflammatory cardiomyopathy has a poor prognosis. The roles of the pathogens, host genomic counterparts and environmental triggers in the progression of disease are still under consideration, including the role of some viruses as active inducers and others as bystanders. In this review article, we review the available evidence on the types, pathogenesis and treatment of myocarditis, inflammatory cardiomyopathy, and atherosclerosis with a particular focus on virus-associated cardiac diseases.

Publisher

Bentham Science Publishers Ltd.

Subject

Drug Discovery,Pharmacology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3